Dry run for vaccine administration will be conducted in Andhra Pradesh, Assam, Gujarat & Punjab next week. This will exercise enable end-to-end mobilisation and testing of COVID-19 vaccination process (except the vaccine) and check the usage of Co-WIN: Govt of India.
Govt is gearing up for roll-out of COVID19 vaccine across the country. Till today, the State level trainings completed in all States/UTs with the participation of more than 7000 district level trainees, except Lakshadweep which will conduct it soon on 29th Dec: Govt of India.
AIIMS based in New Delhi invited volunteers for the Phase III clinical trial of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’
However two dose formula of 21 to 28 days remain intact so second dose test need clarification from ICMR.
𝐈𝐧𝐝𝐢𝐚𝐧 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐂𝐎𝐕𝐈𝐃-19 𝐝𝐫𝐚𝐰𝐬 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧.
ICMR said, “Encouraging Phase I and Phase II COVAXIN trial results have paved the path for Phase III Clinical Trial in India, which is currently ongoing at 22 sites.
India’s indigenous vaccine against #COVID19 Covaxin-a product of ICMR-Bharat Biotech collaboration, achieves remarkable feet. Data generated from within India underlines impressive safety & immunogenicity profile of Covaxin & sparks Lancet’s interest in publishing them: ICMR
UK with covid variant rise has brought 50 nation to travel ban to UK and from UK.
India struggling to trace travellers from UK in Southern states of India. Over 6,000 travellers from U.K. traced across States are being reported. Passengers testing positive moved to separate quarantine units.
In line with a Health Ministry directive, several States have stepped up efforts to trace and test persons who have flown in or transited from the United Kingdom between November 25 and December 23, for a more infective version of the COVID-19 virus.
Flights between India and the U.K. remain suspended till December 31.